In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy

Gut

Volumn 55, Issue 4, 2006, Pages 547-553

  Cagnin, A ^b,c,d   Taylor Robinson, S D ^d   Forton, D M ^d   Banati, R B ^a,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF PADOVA   (Italy)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID;

ADULT; AGED; ARTICLE; BINDING SITE; BRAIN BIOPSY; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; GLIA CELL; GLOBUS PALLIDUS; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; BENZODIAZEPINES; BINDING SITES; BRAIN; COHORT STUDIES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMETRICS;

EID: 33645117570     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.075051     Document Type: Article

References (45)

1. Schenker S, Brady CE. Pathogenesis of hepatic encephalopathy. In: Conn HO, Bircher, J, eds. Hepatic encephalopaphy: syndromes and therapies. Bloomington: Medi-Ed Press, 1994:43-01.
2. Desjardins P, Bandeira P, Rao VLR, et al. Portacaval anastomosis causes selective alterations of peripheral-type benzodiazepine receptor expression in rat brain and peripheral tissues. Neurochem Int 1999;35:293-9.
3. Butterworth RF. The astrocytic ("peripheral-type") benzodiazepine receptor: role in the palhogenesis of portal systemic encephalopathy. Neurochem Int 2000;36:411-16.
4. Anhoh RR, Pedersen PL, DeSouza EB, et al. The peripheral-type benzodiazepine receptor. Localisation to the mitochondrial outer membrane. J Biol Chem 1986;261:776-83.
5. Benavides J, Cornu P, Dennis T, et al. Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol 1988;24:708-12.
6. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 1999;51:629-50.
7. 11C]PK 11195 and comparison of their behaviours as rodioligands for PK binding sites in rats. Nucl Med Biol 1994;21:573-81.
8. Kuhlmann AC, Guilarte TR. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem 2000;74:1694-704.
9. 3H] PK11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 1991;11:314-22.
10. 3H] PK11195 binding to activated microglia. J Neurocytol 1997;26:77-82.
11. Banati RB. Visualising microglial activation in vivo. Glia 2002;40:206-17.
12. Mankowski JL, Queen SE, Tarwater PJ, et al. Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis. J Neurovirol 2003;9:94-100.
13. Ahboucha S, Desjardins P, Chatauret N, et al. Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy. Neurochem Int 2003;45:551-6.
14. Shawcross DL, Davies NA, Williams R, et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247-54.
15. Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 2004;40:327-30.
16. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1972;60:646-9.
17. Conn HO, Leevy CM, Vlahcevic ZR, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind trial. Gastroenterology 1977;72:573-83.
18. Conn HO. Trail making and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541-50.
19. Wechsler D. Wechsler adult intelligence scale manual. New York: Psychological Corporation, 1955.
20. Kendrick DC, Gibson AJ, Moyes IGA. The revised Kendrick battery: clinical studies. Br J Soc Clin Psychol 1979;18:329-39.
21. Taylor-Robinson SD, Sargentoni J, Marcus CD, et al. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopalhy. Metab Brain Dis 1994;9:347-59.
22. 1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996;11:249-68.
23. Taylor-Robinson SD, Buckley C, Changani KK, et al. Cerebral phosphorus-31 and proton magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999;19:389-98.
24. Cognin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001;358:461-7.
25. Grootoonk S, Spinks TJ, Sashin D, et al. Correction for scatter in 3D brain PET using a dual energy window method. Phys Med Biol 1996;41:2757-74.
26. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4:153-8.
27. Gunn RN, Lammerstma AA, Cunningham VJ. Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis. In: Carson R, Daule M, Wilherspoon P, et al. Quantitative functional brain imaging with positron emission tomography. San Diego: Academic Press, 1998:401-6.
28. Banati RB, Newcombe J, Gunn RN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 2000;123:2321-37.
29. Ashbumer J, Haslam J, Taylor C, et al. A cluster analysis approach for the characterization of dynamic PET data. In: Myers R, Cunningnam V, Bailey D, et al. Quantification of brain function using PET. San Diego: Academic Press, 1996:301-6.
30. 11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 2001;124:2014-27.
31. Studholme C, Hill DLG, Hawkes DJ. Automated three dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimisation of voxel similarity measures. Med Phys 1997;24:25-35.
32. Snedecor GW, Cochran WG. Statistical methods, 7th Edn., Iowa State: University Press 1980.
33. Turkheimer FE, Smith CB, Schmidt K. Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data. Neuroimage 2001;13:920-30.
34. 1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995;10:175-88.
35. Lavoie J, Layrargues GP, Butterworth RF. Increased densities of peripheral-type benzoaiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopalhy. Hepotology 1990;11:874-78.
36. Spahr L, Butterworlh RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensily and neurological symptoms. Hepatology 1996;24:116-20.
37. Kulisevsky JJ, Pujol J, Junque C, et al. MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 1993;43:2570-3.
38. Loekwood AH, Murphy BW, Donnelly KZ, et al. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 1993;18:1061-8.
39. Catafau AM, Kulisevsky J, Berna L, et al. Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopalthy. J Nucl Med 2000;41:405-10.
40. 3H]PK11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem 1983;41:1744-50.
41. Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002;40:475-86.
42. Itzhak Y, Roig-Cantisano A, Dombro RS, et al. Acute liver failure and hyperammoniemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995;705:345-8.
43. Graeber MB. Genetics of neuroinflammation in Alzheimer disease. Neurogenetics 1999;2:135-6.
44. Gehrmann J, Mies G, Bonnekoh P, et al. Microglial reaction in the rat cerebral cortex induced by cortical spreading depression. Brain Pathol 1993;3:11-17.
45. Ehninger D, Kempermann G. Regional effects of wheel running and environmental enrichment on cell genesis and microglial proliferation in the adult murine neocortex. Cereb Cortex 2003;13:845-51.